在胰腺管腺癌中向巨细胞导向的病理过程的向:机制和向疗法
Zhou Chen1, Defeng Guan2, Yan Wang1
1Gansu Provincial Hospital, Lanzhou, Gansu, China; The Third Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Cytokine & growth factor reviews
|June 20, 2025
概括
巨细胞促进胰腺癌的生长和扩散,通过促进侵袭性和对治疗的耐药性. 准这些免疫细胞为胰腺管腺癌提供了有前途的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 巨细胞通过分泌因子促进胰腺管腺癌 (PDAC) 的进展.
- 这些免疫细胞增强瘤的侵入性,转移,耐药性和免疫逃避.
- 巨细胞还支持血管生成,创造了一个支持瘤的微环境.
研究的目的:
- 探索巨细胞在PDAC进展中的多方面的作用.
- 突出在PDAC治疗中准巨细胞的治疗潜力.
主要方法:
- 关于巨细胞参与PDAC的当前文献的综述.
- 对巨细胞影响瘤行为的机制的分析.
- 评估新兴的巨细胞向治疗策略.
主要成果:
- 巨细胞分泌细胞因子和酶,增加PDAC的侵入性和转移.
- 巨细胞有助于抵抗化疗,放射治疗和免疫监测.
- 巨驱动的血管生成维持了瘤的生长.
结论:
- 巨细胞是PDAC进展和治疗耐药性的关键参与者.
- 向巨细胞为新型PDAC治疗提供了一个有希望的途径.
- 对巨细胞特异性机制的进一步研究对于开发有效疗法至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:29Chronic Pancreatitis II: Collaborative Care
131
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
131